Combined effect of sodium selenite and campthotecin on cervical carcinoma cells

Neoplasma

Volumn 51, Issue 2, 2004, Pages 127-135

  Rudolf, E ^a   Radocha, J ^a   Cervinka M ^a   Cerman, J ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

Author keywords

Apoptosis; Campthotecin; Cervical cancer; Mitochondria; Selenite

Indexed keywords

CAMPTOTHECIN; CASPASE 3; SELENITE; SELENIUM; SODIUM SELENITE;

ARTICLE; CANCER CELL CULTURE; CELL DEATH; CELL GROWTH; CELL PROLIFERATION; CONTROLLED STUDY; DRUG EFFECT; ENZYME ACTIVATION; HELA CELL; HUMAN; HUMAN CELL; MITOCHONDRION; OXIDATIVE STRESS; UTERINE CERVIX CARCINOMA;

EID: 2342568838     PISSN: 00282685     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. BALDWIN S, PARKER RS. Influence of dietary fat and selenium in initiation and promotion of aflatoxin B1-induced preneoplastic foci in rat liver. Carcinogenesis 1987; 8: 101-107.
2. BHUVARAHAMURTHY V, BALASUBRAMANIAN N, GOVINDASAMY S. Effect of radiotherapy and chemoradiotherapy on circulating antioxidant system of human uterine cervical carcinoma. Mol Cell Biochem 1996; 158:17-23.
3. BOABANG P, KURBACHER CM, KOHLHAGEN H, WAIDA A, AMO-TAKYI BK. Anti-neoplastic activity of topotecan versus cisplatin, etoposide and paclitaxel in four squamous cell cancer cell lines of the female genital tract using an ATP-Tumor Chemosensitivity Assay. Anticancer Drugs 2000; 11: 843-848.
4. CHO DY, JUNG U, CHUNG AS. Induction of apoptosis by selenite and selenodiglutathione in HL-60 cells: correlation with cytotoxicity. Biochem Mol Biol Int 1999; 47: 781-793.
5. COSTELLO AJ. A randomized, controlled chemoprevention trial of selenium in familial prostate cancer: Rationale, recruitment, and design issues. Urology 2001; 57: 182-184.
6. DENG W, WANG DA, GOSMANOVA E, JOHNSON LR, TIGYI G. LPA protects intestinal epithelial cells from apoptosis by inhibiting the mitochondrial pathway. Am J Physiol Gastrointest Liver Physiol 2003; 284: G821-829.
7. DUFFIELD-LILLICO AJ, REID ME, TURNBULL BW, COMBS GF JR, SLATE EH et al. Baseline characteristics and the effect of selenium supplementation on cancer incidence in a randomized clinical trial: a summary report of the Nutritional Prevention of Cancer Trial. Cancer Epidemiol Biomarkers Prev 2002; 11: 630-639.
8. FIORICA JV. Update on the treatment of cervical and uterine carcinoma: focus on topotecan. Oncologist 2002; 7: 36-45.
9. FORMIGLI L, PAPUCCI L, TANI A, SCHIAVONE N, TEMPESTINI A et al. Aponecrosis: morphological and biochemical exploration of a syncretic process of cell death sharing apoptosis and necrosis. J Cell Physiol 2000; 182: 41-49.
10. GANTHER HE. Selenium metabolism and mechanisms of cancer prevention. Adv Exp Med Biol 2001; 492: 119-130.
11. HSIANG Y, LIU L. Identification of DNA topoisomerase I as an intacellular target of the anticancer drug CPT. Cancer Res 1988; 48: 1722-1726.
12. HUSSAIN SP, RAO AR. Chemopreventive action of selenium on methylcholanthrene-induced carcinogenesis in the uterine cervix of mouse. Oncology 1992; 49: 237-240.
13. IP C, DONG Y, GANTHER HE. New concepts in selenium chemoprevention. Cancer Metastasis Rev 2002; 21: 281-289.
14. KAKOLYRIS S, KOUROUSSIS C, SOUGLAKOS J, MAVROUDIS D, AGELAKIS et al. A phase I clinical trial of topotecan given every 2 weeks in patients with refractory solid tumors. Oncology 2001; 61: 265-270.
15. KAUFMANN SH. Induction of endonucleolytic DNA cleavage in human acute myelogenous leukemia cells by etoposide, CPT and other cytotoxic anticancer drugs: a cautionary note. Cancer Res 1989; 49: 5870-5878.
16. KRISHNAN K, CAMPBELL S, ABDEL-RAHMAN F, WHALEY S, STONE WL. Cancer chemoprevention drug targets. Curr Drug Targets 2003; 4: 45-54.
17. LANFEAR J, FLEMING J, WU L, WEBSTER G, HARRISON PR. The selenium metabolite selenodiglutathione induces p53 and apoptosis: relevance to the chemopreventive effects of selenium? Carcinogenesis 1994; 15: 1387-1392.
18. LEE S, LEE HS, BAEK M, LEE DY, BANG YJ et al. MAPK signaling is involved in CPT-induced cell death. Mol Cells 2002; 14: 348-354.
19. LI J, ZUO L, SHEN T, XU CM, ZHANG ZN. Induction of apoptosis by sodium selenite in human acute promyelocytic leukemia NB4 cells: involvement of oxidative stress and mitochondria. J Trace Elem Med Biol 2003; 17: 19-26.
20. MILLER S, WALKER SW, ARTHUR JR, NICOL F, PICKARD K et al. Selenite protects human endothelial cells from oxidative damage and induces thioredoxin reductase. Clin Sci (Lond) 2001; 100: 543-550.
21. MUGGIA FM, DIMERY I, ARBUCK SG. CPT and its analogs. An overview of their potential in cancer therapeutics. Ann NY Acad Sci 1996; 803: 213-223.
22. RAFFERTY TS, BECKETT GJ, WALKER C, BISSET YC, McKENZIE RC. Selenium protects primary human keratinocytes from apoptosis induced by exposure to ultraviolet radiation. Clin Exp Dermatol 2003; 28: 294-300.
23. ROSE PG. Combined-modality therapy of locally advanced cervical cancer. J Clin Oncol 2003; 21: 211-217.
24. RUDOLF E, RUDOLF K, RADOCHA J, PEYCHL J, ČERVINKA M. The role of intracellular zinc in modulation of life and death of Hep-2 cells. Biometals 2003; 16: 295-309.
25. SORDET O, KHAN QA, KOHN KW. POMMIER Y. Apoptosis induced by topoisomerase inhibitors. Curr Med Chem Anti-Canc Agents 2003; 3: 271-290.
26. STEWART MS, SPALLHOLZ JE, NELDNER KH, PENCE BC. Selenium compounds have disparate abilities to impose oxidative stress and induce apoptosis. Free Radic Biol Med 1999; 26: 42-48.
27. TAPIERO H, TOWNSEND DM, TEW KD. The antioxidant role of selenium and seleno-compounds. Biomed Pharmacother 2003; 57: 134-144.
28. THIRUNAVUKKARASU C, SAKTHISEKARAN D. Influence of sodium selenite on glycoprotein contents in normal and N-nitrosodiethylamine initiated and phenobarbital promoted rat liver tumors. Pharmacol Res 2003; 48: 167-173.
29. VADGAMA JV, WE Y, SHEN D, HSIA S, BLOCK J. Effect of selenium in combination with adriamycin and taxol on several different cancer cells. Anticancer Res 2000; 30: 1391-1414.
30. WILSON CA, BROWNING JL. Death of HT29 adenocarcinoma cells induced by TNF family receptor activation is caspase-independent and displays features of both apoptosis and necrosis. Cell Death Differ 2002; 9: 1321-1333.
31. WOUTERSEN RA, APPEL MJ, VAN GARDEREN-HOETMER A. Modulation of pancreatic carcinogenesis by antioxidants. Food Chem Toxicol 1999; 37: 981-984.
32. XIA L, NORDMAN T, OLSSON JM, DAMDIMOPOULOS A, BJORKHEM-BERGMAN L et al. The mammalian cytosolic selenoenzyme thioredoxin reductase reduces ubiquinone. A novel mechanism for defense against oxidative stress. J Biol Chem 2003; 278: 2141-2146.
33. ZHOU N, XIAO H, LI TK, NUR-E-KAMAL A, LIU LF. DNA damage-mediated apoptosis induced by selenium compounds. J Biol Chem 2003 (pub ahead of print).